--- type: "Topics" locale: "en" url: "https://longbridge.com/en/topics/45052122.md" description: "$BAO PHARMA-B(02659.HK) surged +21% on Thursday, with trading volume exceeding seven times the daily average, closing at HKD 11.4. Last week, the approval of BJ045 combined with the chairman's share purchases drove a weekly amplitude of over 40%. With no new announcements on Thursday, capital continued to push the price higher along the existing catalysts. Amid a day where Hong Kong tech stocks generally weakened, it stood out as one of the few small-cap biotechs seeing increased volume and solid buying support. The stock pulled back to HKD 10.44 the next day as momentum traders took profits. The commercial ramp-up for BJ045 awaits subsequent sales data, but the market had already priced in the approval expectations." datetime: "2026-11-13T09:00:12.000Z" locales: - [en](https://longbridge.com/en/topics/45052122.md) - [zh-CN](https://longbridge.com/zh-CN/topics/45052122.md) - [zh-HK](https://longbridge.com/zh-HK/topics/45052122.md) author: "[主要靠运气](https://longbridge.com/en/profiles/27426993.md)" generator: "portal-rs" --- # $BAO PHARMA-B(02659.HK) surged +21% on Thursday, w… ### Related Stocks - [02659.HK](https://longbridge.com/en/quote/02659.HK.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**